Outpatient follow-up of OPAT patients reduces readmission

0

We conducted a pair-matched case-control study to examine the association between outpatient infectious disease follow-up and the risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy (OPAT)” Saini et al (2019).

Abstract:

We conducted a pair-matched case-control study to examine the association between outpatient infectious disease follow-up and the risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy (OPAT). We found ID outpatient follow-up within 2 weeks was associated with a lower risk of all-cause 30-day readmission (aOR=0.33, p-value=0.0001).

You may also be interested in…





Reference:

Saini, E., Ali, M., Du, P., Crook, T. and Zurlo, J. (2019) Early ID Outpatient Follow-up of OPAT Patients Reduces 30-Day Readmission. Clinical Infectious Diseases. February 4th. .

doi: 10.1093/cid/ciz073.

Share.

Comments are closed.